Intracranial haemorrhage in a boy with severe haemophilia A and factor VIII inhibitor

被引:3
|
作者
Laguna P. [1 ]
Klukowska A. [1 ]
机构
[1] Department of Paediatrics, Haematology and Oncology, Warsaw Medical University, 00-576 Warsaw
关键词
Factor VIII inhibitor; Haemophilia A; Intracranial haemorrhage; Recombinant activated factor VII (rFVIIa);
D O I
10.1007/s00381-005-1168-7
中图分类号
学科分类号
摘要
Background: This report describes the case of a boy with severe haemophilia A and factor VIII inhibitor who suffered subarachnoid haemorrhage at age 7 years, followed by bleeding in the right cerebellar hemisphere and an epidural haematoma at age 12 years. Method: The patie nt received intensive replacement treatment leading to reversal of neurological signs and symptoms and resorption of haematomas, as demonstrated by CT scans. © Springer-Verlag 2005.
引用
收藏
页码:432 / 435
页数:3
相关论文
共 50 条
  • [21] Optimizing efficacy of factor VIII prophylaxis for severe haemophilia A
    Fischer, K.
    HAEMOPHILIA, 2011, 17 : 9 - 15
  • [22] Intracranial haemorrhage in a neonate with severe haemophilia A: A case report and literature review
    Kotnik, Barbara Faganel
    Kitanovski, Lidija
    Rajic, Vladan
    Paro-Panjan, Darja
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (03): : 253 - 260
  • [23] HLA class II profile: A weak determinant of factor VIII inhibitor development in severe haemophilia A
    Hay, CRM
    Ollier, W
    Pepper, L
    Cumming, A
    Keeney, S
    Goodeve, AC
    Colvin, BT
    Hill, FGH
    Preston, FE
    Peake, IR
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (02) : 234 - 237
  • [24] Joint bleeds increase the inhibitor response to human factor VIII in a rat model of severe haemophilia A
    Lovgren, K. M.
    Sondergaard, H.
    Skov, S.
    Wiinberg, B.
    HAEMOPHILIA, 2016, 22 (05) : 772 - 779
  • [25] HLA class II profile: A determinant of factor VIII inhibitor development in severe haemophilia A.
    Hay, CRM
    Ollier, W
    Pepper, L
    Cumming, A
    Keeney, S
    Goodeve, AC
    Peake, IR
    BLOOD, 1996, 88 (10) : 1306 - 1306
  • [26] Hla class II profile: A determinant of factor VIII inhibitor development in severe haemophilia A.
    Hay, CRM
    Ollier, W
    Pepper, L
    Cumming, A
    Preston, FE
    Hill, FGH
    Colvin, BT
    Ludlam, CA
    Peake, IR
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 231 - 231
  • [27] Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor
    Ashrani, AA
    Reding, MT
    Shet, A
    Osip, J
    Humar, A
    Lake, JR
    Key, NS
    HAEMOPHILIA, 2004, 10 (06) : 735 - 737
  • [28] Acquired factor VIII inhibitor presenting as macular haemorrhage
    Hon, C
    Liu, H
    Chan, J
    HAEMOPHILIA, 2005, 11 (02) : 164 - 166
  • [29] An acquired factor VIII inhibitor in association with a myeloproliferative/myelodysplastic disorder presenting with severe subcutaneous haemorrhage
    Biss, T
    Crossman, L
    Neilly, I
    Hanley, J
    HAEMOPHILIA, 2003, 9 (05) : 638 - 641
  • [30] A pharmacokinetic model for factor VIII dosing during active haemorrhage in patients with haemophilia A
    Ho, AMH
    Dion, P
    Karmakar, MK
    Cheng, G
    Derrick, JL
    Chung, DC
    Tay, BA
    ANAESTHESIA, 2001, 56 (08) : 785 - 790